219 related articles for article (PubMed ID: 31243026)
21. Efficacy of ibrutinib in the treatment of Bing-Neel syndrome.
Cabannes-Hamy A; Lemal R; Goldwirt L; Poulain S; Amorim S; Pérignon R; Berger J; Brice P; De Kerviler E; Bay JO; Sauvageon H; Beldjord K; Mourah S; Tournilhac O; Thieblemont C
Am J Hematol; 2016 Mar; 91(3):E17-9. PubMed ID: 26689870
[No Abstract] [Full Text] [Related]
22. Diagnosing, imaging, and successfully treating a debilitating case of Bing-Neel syndrome: A multidisciplinary feat.
Kerley RN; O'Donnell N; Lynott F; Mulcahy R; Hennessy B
Clin Case Rep; 2023 May; 11(5):e7296. PubMed ID: 37151950
[TBL] [Abstract][Full Text] [Related]
23. Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report.
Barnes M; Sharma P; Kumar V; Kaell A; LiPera W
J Med Case Rep; 2020 Jul; 14(1):98. PubMed ID: 32654665
[TBL] [Abstract][Full Text] [Related]
24. Bing-Neel Syndrome: Illustrative Cases and Comprehensive Review of the Literature.
Varettoni M; Defrancesco I; Diamanti L; Marchioni E; Farina LM; Pichiecchio A
Mediterr J Hematol Infect Dis; 2017; 9(1):e2017061. PubMed ID: 29181138
[TBL] [Abstract][Full Text] [Related]
25. Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study.
Castillo JJ; Itchaki G; Paludo J; Varettoni M; Buske C; Eyre TA; Chavez JC; Shain KH; Issa S; Palomba ML; Pasvolsky O; Simpson D; Talaulikar D; Tam CS; Tedeschi A; Ansell SM; Nayak L; Treon SP
Blood; 2019 Jan; 133(4):299-305. PubMed ID: 30523119
[TBL] [Abstract][Full Text] [Related]
26. MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome.
Poulain S; Boyle EM; Roumier C; Demarquette H; Wemeau M; Geffroy S; Herbaux C; Bertrand E; Hivert B; Terriou L; Verrier A; Pollet JP; Maurage CA; Onraed B; Morschhauser F; Quesnel B; Duthilleul P; Preudhomme C; Leleu X
Br J Haematol; 2014 Nov; 167(4):506-13. PubMed ID: 25160558
[TBL] [Abstract][Full Text] [Related]
27. [IgG-variant Bing-Neel syndrome diagnosed by detecting MYD88 L265P mutation in the cerebrospinal fluid cells].
Maruyama Y; Nishikii H; Matsuoka R; Makishima K; Kurita N; Kusakabe M; Yokoyama Y; Kato T; Sakata-Yanagimoto M; Obara N; Nakamura N; Chiba S
Rinsho Ketsueki; 2021; 62(10):1493-1498. PubMed ID: 34732622
[TBL] [Abstract][Full Text] [Related]
28. Bing-Neel syndrome: Two unexpected cases and a review of the literature.
Van Cauwenberge MG; Depreter B; Dumoulin EN; Emmerechts J; Nollet F; Vanopdenbosch LJ
J Neurol Sci; 2015 Sep; 356(1-2):19-26. PubMed ID: 26159625
[TBL] [Abstract][Full Text] [Related]
29. A man in his 70s with neurological symptoms and progressive pain during cancer therapy.
Tholin B; Köster AK; Standal PA
Tidsskr Nor Laegeforen; 2020 Feb; 140(2):. PubMed ID: 32026856
[TBL] [Abstract][Full Text] [Related]
30. Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.
Talaulikar D; Tam CS; Joshua D; Ho JP; Szer J; Quach H; Spencer A; Harrison S; Mollee P; Roberts AW; Horvath N; Lee C; Zannettino A; Brown R; Augustson B; Jaksic W; Gibson J; Kalff A; Johnston A; Trotman J; Kalro A; Grigoriadis G; Ward C; Prince HM
Intern Med J; 2017 Jan; 47(1):35-49. PubMed ID: 28076910
[TBL] [Abstract][Full Text] [Related]
31. Anemia - an initial manifestation of Bing-Neel syndrome: A case report.
Yang X; Chong Z; Ma C; Wang G; Yan C
Medicine (Baltimore); 2022 Nov; 101(46):e31239. PubMed ID: 36401435
[TBL] [Abstract][Full Text] [Related]
32. [Recurrent meningitis revealing a Bing-Neel syndrome].
Sobczak T; Alleman L; Wille H; Menard F; Benard Y; Perard B; Vareil MO
Rev Med Interne; 2021 May; 42(5):359-362. PubMed ID: 33663872
[TBL] [Abstract][Full Text] [Related]
33. TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenström macroglobulinaemia.
Gustine JN; Tsakmaklis N; Demos MG; Kofides A; Chen JG; Liu X; Munshi M; Guerrera ML; Chan GG; Patterson CJ; Meid K; Dubeau T; Yang G; Hunter ZR; Treon SP; Castillo JJ; Xu L
Br J Haematol; 2019 Jan; 184(2):242-245. PubMed ID: 30183082
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic experience of Bing-Neel Syndrome associated with Waldenstrom's macroglobulinemia.
Kim HD; Shin KC; Cho HS; Kim MK; Lee KH; Hyun MS
J Korean Med Sci; 2007 Dec; 22(6):1079-81. PubMed ID: 18162727
[TBL] [Abstract][Full Text] [Related]
35. MYD88 Mutations and Response to Ibrutinib in Waldenström's Macroglobulinemia.
Treon SP; Xu L; Hunter Z
N Engl J Med; 2015 Aug; 373(6):584-6. PubMed ID: 26244327
[No Abstract] [Full Text] [Related]
36. First-line ibrutinib for Bing-Neel syndrome.
Tallant A; Selig D; Wanko SO; Roswarski J
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30279255
[TBL] [Abstract][Full Text] [Related]
37. Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.
Dimopoulos MA; Trotman J; Tedeschi A; Matous JV; Macdonald D; Tam C; Tournilhac O; Ma S; Oriol A; Heffner LT; Shustik C; García-Sanz R; Cornell RF; de Larrea CF; Castillo JJ; Granell M; Kyrtsonis MC; Leblond V; Symeonidis A; Kastritis E; Singh P; Li J; Graef T; Bilotti E; Treon S; Buske C;
Lancet Oncol; 2017 Feb; 18(2):241-250. PubMed ID: 27956157
[TBL] [Abstract][Full Text] [Related]
38. [Bing-Neel syndrome revealing Waldenström's macroglobulinemia].
Drouet T; Behin A; Psimaras D; Choquet S; Guillevin R; Hoang Xuan K
Rev Neurol (Paris); 2010 Jan; 166(1):66-75. PubMed ID: 19403149
[TBL] [Abstract][Full Text] [Related]
39. [Bing-Neel syndrome: Report of 4 cases and literature review].
Boudin L; Romeo E; Mavrovi E; Tsitsi Nding P; Blade JS; de Jaureguiberry JP; Gisserot O
Rev Med Interne; 2015 Jun; 36(6):418-22. PubMed ID: 24907109
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of ibrutinib as first-line treatment of tumoral Bing-Neel syndrome.
Boudin L; Patient M; Roméo E; Bladé JS; de Jauréguiberry JP
Leuk Lymphoma; 2018 Nov; 59(11):2746-2748. PubMed ID: 29569974
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]